Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX cash
Cash and short-term investments held at the end of each period.
Zeo ScientifiX's cash was $1.85M at Apr 30, 2026. For fiscal 2025 it was $221.00K, down 66.4% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $3.75M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $221.00K | -66.4% |
| FY2024 | Oct 31, 2024 | $657.00K | -62.6% |
| FY2023 | Oct 31, 2023 | $1.76M | -53.2% |
| FY2022 | Oct 31, 2022 | $3.75M | +3356.8% |
| FY2021 | Oct 31, 2021 | $108.57K | -81.6% |
| FY2020 | Oct 31, 2020 | $590.80K | +345.7% |
| FY2019 | Oct 31, 2019 | $132.56K | +208.2% |
| FY2018 | Oct 31, 2018 | $43.02K | +8.7% |
| FY2017 | Oct 31, 2017 | $39.56K | +50.9% |
| FY2016 | Oct 31, 2016 | $26.22K | -30.2% |
| FY2015 | Oct 31, 2015 | $37.57K | +15295.5% |
| FY2014 | Oct 31, 2014 | $244 | -98.5% |
| FY2013 | Oct 31, 2013 | $15.95K | +584.8% |
| FY2012 | Oct 31, 2012 | $2.33K | -80.7% |
| FY2011 | Oct 31, 2011 | $12.07K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $1.85M | +240.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $1.03M | +43.1% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $221.00K | -66.4% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $314.00K | -57.9% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $542.00K | -53.8% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $720.00K | -59.0% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $657.00K | +3.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $746.00K | -34.0% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $1.17M | -68.8% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $1.76M | +2251.8% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $633.00K | +859.1% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $1.13M | +652.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $3.75M | +3356.8% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $74.67K | +155.6% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $66.00K | -66.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $150.32K | -74.6% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $108.57K | -65.7% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $29.21K | -88.5% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $195.92K | +37.7% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $590.80K | +345.7% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $316.95K | +766.5% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $254.18K | +109.4% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $142.27K | +230.7% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $132.56K | +558.7% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $36.58K | +7851.7% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $121.37K | +213.5% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $43.02K | +8.7% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $20.13K | +508.9% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $460 | -99.6% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $38.71K | -9.8% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $39.56K | +50.9% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $3.31K | -56.1% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $103.17K | +170.3% |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $42.91K | +833.3% |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $26.22K | -30.2% |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $7.53K | -94.1% |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | $38.17K | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | $4.60K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | $37.57K | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | $127.27K | – |
See a number that looks wrong?